rab
vincentmunst
nihgov
vjm
author
contribut
equal
articl
abstract
merscov
present
dromedari
camel
throughout
middl
east
africa
dromedari
camel
primari
zoonot
reservoir
human
infect
interrupt
zoonot
transmiss
chain
camel
human
therefor
may
effect
strategi
control
ongo
merscov
outbreak
show
vaccin
adjuv
merscov
spike
protein
subunit
vaccin
confer
complet
protect
merscov
diseas
alpaca
result
reduc
delay
viral
shed
upper
airway
dromedari
camel
protect
alpaca
correl
high
serum
neutral
antibodi
titer
lower
titer
serum
neutral
antibodi
correl
delay
significantli
reduc
shed
nasal
turbin
dromedari
camel
togeth
data
indic
induct
robust
neutral
humor
immun
respons
vaccin
anim
reduc
shed
potenti
could
diminish
risk
zoonot
transmiss
viru
isol
serolog
studi
suggest
merscov
present
dromedari
camel
least
three
decad
region
wide
rang
middl
east
north
africa
east
africa
outbreak
among
human
popul
persistedalbeit
low
numbersdespit
lack
sustain
humantohuman
transmiss
data
molecular
epidemiolog
studi
suggest
outbreak
endur
multipl
zoonot
spillov
event
dromedari
camel
human
addit
sever
studi
saudi
arabia
qatar
demonstr
clear
epidemiolog
link
camel
human
popul
although
merscov
typic
caus
sever
pneumonia
human
viru
primarili
infect
upper
respiratori
tract
dromedari
camel
viabl
viru
shed
high
quantiti
approxim
day
viral
rna
detect
day
occup
exposur
involv
close
proxim
infect
dromedari
camel
major
risk
factor
human
acquisit
risk
profil
confirm
studi
saudi
arabia
camel
herder
slaughterhous
worker
much
like
gener
popul
either
serolog
evid
past
exposur
high
case
fatal
rate
continu
zoonot
transmiss
sustain
anim
reservoir
merscov
underscor
need
intervent
strategi
focus
prevent
zoonot
transmiss
evalu
efficaci
intramuscular
adjuv
subunit
vaccin
prevent
infect
reduc
shed
dromedari
camel
camelu
dromedariu
alpaca
vicugna
paco
materi
method
supplementari
materi
follow
avail
onlin
sinc
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
confirm
human
case
death
yield
case
fatal
ratio
nearli
case
either
occur
export
middl
east
dromedari
camel
identifi
primari
reservoir
merscov
multipl
studi
employ
combin
diagnost
platform
includ
serolog
molecular
detect
viral
rna
dna
express
vector
produc
encod
portion
spike
glycoprotein
merscov
strain
strain
genbank
id
figur
sequenc
reversetransl
codonoptim
human
cell
express
describ
protein
produc
transfect
cell
mammalian
express
vector
express
codonoptim
gene
protein
purifi
transfect
cell
cultur
supernat
histrap
hp
hiload
superdex
column
ge
healthcar
piscataway
nj
usa
store
c
pb
use
experi
approv
colorado
state
univers
institut
anim
care
use
committe
work
infecti
merscov
strain
condit
approv
institut
biosafeti
committe
ibc
inactiv
remov
sampl
high
contain
perform
accord
ibcapprov
standard
evalu
effect
vaccin
merscov
shed
use
actual
anim
reservoir
camel
surrog
infect
model
alpaca
five
merscov
seroneg
dromedari
camel
four
alpaca
purchas
privat
sale
use
studi
anim
born
unit
state
adult
intact
male
alpaca
one
intact
adult
male
one
castrat
adult
male
one
adult
femal
vaccin
dromedari
camel
three
intact
male
dromedari
camel
unvaccin
control
anim
anim
fed
ad
libitum
hous
outdoor
pen
immun
move
anim
biosafeti
level
facil
one
week
prior
challeng
allow
acclim
facil
vaccin
anim
given
protein
combin
mg
advax
hcxl
adjuv
delta
inulin
formul
vaxin
pti
ltd
bedford
park
sa
australia
two
ml
intramuscular
inject
given
shoulder
day
day
given
protein
sigma
adjuv
system
oilinwat
emuls
sigmaaldrich
st
loui
mo
usa
day
advax
adjuv
chosen
stimul
broad
immunogen
dromedari
camel
sigma
adjuv
system
known
induct
merscov
neutral
antibodi
anim
challeng
merscov
strain
three
group
along
stagger
schedul
due
facil
limit
group
inocul
day
first
vaccin
consist
vaccin
camel
group
inocul
day
first
vaccin
consist
unvaccin
camel
vaccin
alpaca
group
inocul
day
first
vaccin
consist
vaccin
camel
unvaccin
alpaca
anim
sedat
xylazin
inocul
intranas
total
dose
tcid
human
isol
merscov
strain
describ
previous
camel
inocul
ml
per
nare
alpaca
inocul
ml
per
nare
anim
evalu
least
daili
temperatur
nasal
discharg
activ
level
food
consumpt
nasal
swab
collect
daili
place
immedi
viral
transport
medium
viru
lysi
buffer
frozen
process
anim
sedat
day
postinocul
human
euthan
intraven
pentobarbit
follow
tissu
collect
viral
isol
formalinfix
immunohistochemistri
histopatholog
nasal
turbin
larynx
trachea
lung
right
apic
left
apic
right
caudal
left
caudal
lobe
kidney
spleen
mediastin
mesenter
lymph
node
muscl
histor
sampl
previous
infect
camel
euthan
day
post
inocul
includ
addit
control
present
studi
correspond
camel
public
adney
et
al
b
schemat
overview
immun
timelin
immun
blue
arrow
serum
sampl
red
triangl
challeng
euthanasia
black
arrow
time
point
indic
c
neutral
antibodi
titer
dromedari
camel
alpaca
vaccin
adjuv
merscov
determin
prnt
neutral
anim
challeng
intranas
tissu
cultur
infecti
dose
merscov
strain
euthan
necropsi
day
postinocul
dpi
unvaccin
control
camel
develop
mild
clinic
diseas
nasal
discharg
observ
concurr
control
camel
dpi
quickli
resolv
observ
nasal
discharg
detect
vaccin
camel
alpaca
minor
temperatur
fluctuat
blood
collect
day
first
vaccin
time
challeng
day
serumsepar
tube
serum
analyz
merscov
neutral
activ
plaqu
reduct
neutral
test
prnt
describ
previous
use
neutral
cutoff
nasal
swab
tissu
sampl
titrat
plaqu
assay
vero
cell
short
homogen
tissu
titrat
medium
plaqu
count
day
follow
second
overlay
describ
previous
rna
extract
swab
urin
fecal
sampl
use
qiaamp
viral
rna
kit
qiagen
detect
viral
rna
rna
use
onestep
realtim
rtpcr
upe
assay
use
rotorgenetm
probe
kit
qiagen
describ
previous
standard
dilut
titer
viru
stock
run
parallel
calcul
tcid
equival
sampl
total
rna
nasal
turbin
tissu
sampl
dromedari
camel
alpaca
extract
use
rneasi
mini
kit
qiagen
cdna
synthes
use
random
hexam
high
capac
rna
cdna
kit
thermo
fisher
waltham
usa
cdna
subsequ
use
pcramplifi
merscov
use
iproof
highfidel
dna
polymeras
biorad
hercul
ca
usa
accord
manufactur
protocol
primer
sequenc
avail
upon
request
sequenc
assembl
seqman
pro
dnastar
madison
wi
usa
analyz
megalign
dnastar
madison
wi
usa
comparison
merscov
strain
input
sequenc
dromedari
camel
alpaca
tissu
evalu
patholog
presenc
viral
antigen
tissu
fix
day
neutralbuff
formalin
place
cassett
process
sakura
tissu
tek
autom
schedul
use
grade
seri
ethanol
xylen
paraplast
extra
embed
tissu
section
dri
overnight
degre
c
prior
stain
tissu
process
immunohistochemistri
use
discoveri
xt
autom
processor
ventana
medic
system
dabmap
ventana
medic
system
kit
detect
merscov
antigen
immunohistochemistri
perform
use
rabbit
polyclon
antiserum
primari
antibodi
describ
previous
grade
histopatholog
immunohistochemistri
done
blind
boardcertifi
veterinari
pathologist
p
valu
calcul
anova
sidak
multipl
comparison
test
use
prism
softwar
version
graphpad
la
jolla
ca
usa
statist
signific
differ
met
threshold
three
dromedari
camel
two
alpaca
vaccin
adjuv
subunit
vaccin
three
camel
serv
unvaccin
control
histor
control
two
alpaca
serv
unvaccin
control
alpaca
group
anim
vaccin
day
protein
figur
coformul
mg
advax
tm
hcxl
adjuv
vaxin
pti
ltd
adelaid
australia
admix
product
deliv
time
point
two
ml
intramuscular
inject
shoulder
anim
boost
day
protein
emulsifi
sigma
adjuv
system
sigma
aldrich
co
llc
st
loui
mo
usa
complet
immun
schedul
figur
serum
vaccin
anim
collect
evalu
plaqu
reduct
neutral
test
prnt
merscov
strain
figur
day
prime
vaccin
low
level
merscov
neutral
antibodi
detect
two
three
camel
viru
neutral
titer
respect
figur
day
boost
result
increas
neutral
titer
prnt
assay
neutral
titer
decreas
second
third
boost
third
immun
result
quick
increas
neutral
titer
two
camel
respond
vaccin
neutral
titer
high
two
camel
time
challeng
neutral
antibodi
detect
point
experi
figur
stronger
neutral
respons
observ
alpaca
vaccin
viru
neutral
titer
four
week
initi
vaccin
end
titer
time
challeng
figur
anim
challeng
intranas
tissu
cultur
infecti
dose
tcid
merscov
strain
euthan
necropsi
day
postinocul
dpi
unvaccin
control
camel
develop
mild
clinic
diseas
nasal
discharg
observ
concurr
control
camel
dpi
quickli
resolv
observ
nasal
discharg
detect
vaccin
camel
alpaca
minor
temperatur
fluctuat
detect
sever
camel
alpaca
howev
appreci
fever
associ
infect
figur
viru
shed
first
detect
nasal
swab
unvaccin
control
camel
dpi
everi
day
thereaft
euthanasia
dpi
figur
despit
presenc
neutral
antibodi
two
three
vaccin
camel
anim
shed
viru
challeng
two
vaccin
camel
detect
humor
immun
respons
exhibit
reduc
viral
shed
dpi
dpi
differ
merscov
titer
measur
nasal
swab
vaccin
control
camel
vaccin
camel
without
detect
neutral
antibodi
titer
shed
viru
dpi
otherwis
exhibit
viru
shed
kinet
similar
unvaccin
control
overal
infecti
merscov
titer
nasal
swab
differ
statist
significantli
vaccin
unvaccin
camel
dpi
p
contrast
camel
vaccin
alpaca
result
complet
protect
merscov
shed
infecti
viru
detect
nasal
swab
collect
vaccin
alpaca
infecti
viru
detect
unvaccin
alpaca
everi
day
necropsi
dpi
figur
infecti
viru
detect
nasal
turbin
larynx
trachea
unvaccin
camel
figur
confirm
viru
stock
prepar
challeng
result
product
infect
addit
infecti
viru
detect
lung
lobe
three
vaccin
camel
infecti
viru
nasal
turbin
titer
similar
unvaccin
camel
howev
viru
titer
larynx
trachea
significantli
lower
vaccin
camel
unvaccin
control
figur
viral
rna
also
detect
outsid
respiratori
tract
camel
predominantli
lymph
node
figur
unvaccin
alpaca
high
titer
infecti
viru
present
nasal
turbin
lower
titer
larynx
trachea
neither
infecti
viru
viral
rna
could
detect
respiratori
tract
tissu
vaccin
alpaca
figur
figur
unvaccin
control
alpaca
low
amount
viral
genom
rna
detect
outsid
respiratori
tract
figur
infecti
viru
detect
nasal
turbin
larynx
trachea
unvaccin
camel
figur
confirm
viru
stock
prepar
challeng
result
product
infect
addit
infecti
viru
detect
lung
lobe
three
vaccin
camel
infecti
viru
nasal
turbin
titer
similar
unvaccin
camel
howev
viru
titer
larynx
trachea
significantli
lower
vaccin
camel
unvaccin
control
figur
viral
rna
also
detect
outsid
respiratori
tract
camel
predominantli
lymph
node
figur
unvaccin
alpaca
high
titer
infecti
viru
present
nasal
turbin
lower
titer
larynx
trachea
neither
infecti
viru
viral
rna
could
detect
respiratori
tract
tissu
vaccin
alpaca
figur
figur
unvaccin
control
alpaca
low
amount
viral
genom
rna
detect
outsid
respiratori
tract
figur
camel
display
histolog
section
multifoc
minimaltomild
acut
rhiniti
figur
g
nasal
turbin
exhibit
loss
cilia
cellular
polar
occasion
necrot
epitheli
cell
admix
small
number
neutrophil
rare
eros
respiratori
epithelium
underli
submucosa
infiltr
smalltomoder
number
lymphocyt
plasma
cell
fewer
macrophag
neutrophil
nonrespons
vaccin
camel
control
display
minimaltomild
multifoc
acut
tracheiti
evidenc
loss
individu
epitheli
cell
cell
polar
necrosi
infiltr
epithelium
small
number
neutrophil
observ
none
camel
show
patholog
chang
lower
respiratori
tract
figur
c
h
immunohistochemistri
ihc
demonstr
presenc
merscov
antigen
epitheli
cell
nasal
turbin
figur
j
viral
antigen
also
detect
tracheal
epitheli
cell
figur
camel
display
histolog
section
multifoc
minimaltomild
acut
rhiniti
figur
g
nasal
turbin
exhibit
loss
cilia
cellular
polar
occasion
necrot
epitheli
cell
admix
small
number
neutrophil
rare
eros
respiratori
epithelium
underli
submucosa
infiltr
smalltomoder
number
lymphocyt
plasma
cell
fewer
macrophag
neutrophil
nonrespons
vaccin
camel
control
display
minimaltomild
multifoc
acut
tracheiti
evidenc
loss
individu
epitheli
cell
cell
polar
necrosi
infiltr
epithelium
small
number
neutrophil
observ
none
camel
show
patholog
chang
lower
respiratori
tract
figur
c
h
immunohistochemistri
ihc
demonstr
presenc
merscov
antigen
epitheli
cell
nasal
turbin
figur
j
viral
antigen
also
detect
tracheal
epitheli
cell
figur
similar
camel
unvaccin
alpaca
display
multifoc
minimaltomild
acut
rhiniti
figur
loss
cilia
cellular
polar
occasion
necrot
epitheli
cell
admix
small
number
neutrophil
rare
eros
respiratori
epithelium
subjac
submucosa
infiltr
smalltomoder
number
lymphocyt
plasma
cell
fewer
macrophag
neutrophil
ihc
confirm
presenc
merscov
antigen
within
epitheli
cell
nasal
turbin
control
alpaca
figur
histopatholog
chang
merscov
antigen
detect
vaccin
alpaca
figur
similar
camel
unvaccin
alpaca
display
multifoc
minimaltomild
acut
rhiniti
figur
loss
cilia
cellular
polar
occasion
necrot
epitheli
cell
admix
small
number
neutrophil
rare
eros
respiratori
epithelium
subjac
submucosa
infiltr
smalltomoder
number
lymphocyt
plasma
cell
fewer
macrophag
neutrophil
ihc
confirm
presenc
merscov
antigen
within
epitheli
cell
nasal
turbin
control
alpaca
figur
histopatholog
chang
merscov
antigen
detect
vaccin
alpaca
figur
l
given
import
zoonot
reservoir
merscov
sustain
current
human
epidem
strategi
interrupt
transmiss
dromedari
camel
human
may
serv
effect
countermeasur
strategi
implement
set
hendra
viru
infect
australia
vaccin
hors
aim
interrupt
transmiss
chain
hendra
viru
fruit
bat
hors
human
likewis
dromedari
camel
driver
zoonot
transmiss
merscov
vaccin
dromedari
camel
reduc
shed
merscov
would
like
limit
potenti
zoonot
transmiss
larg
fraction
dromedari
camel
middl
east
north
east
africa
antibodi
specif
merscov
degre
protect
reinfect
provid
antibodi
current
unclear
evid
point
abil
merscov
reinfect
dromedari
camel
despit
presenc
antibodi
serum
merscov
seroposit
camel
still
shed
detect
merscov
respiratori
tract
found
middl
east
howev
correl
strong
humor
respons
seroposit
adult
dromedari
camel
low
preval
merscov
observ
jordan
wherea
seroposit
young
camel
year
old
weaker
humor
respons
display
high
merscov
preval
suggest
antibodi
merscov
afford
protect
reinfect
viru
shed
observ
also
suggest
younger
anim
main
drive
forc
behind
circul
merscov
primari
target
vaccin
strategi
studi
highlight
sever
import
issu
consid
develop
dromedari
camel
vaccin
merscov
first
viru
shed
reduc
complet
absent
presenc
antibodi
dromedari
camel
vaccin
howev
viru
replic
given
import
zoonot
reservoir
merscov
sustain
current
human
epidem
strategi
interrupt
transmiss
dromedari
camel
human
may
serv
effect
countermeasur
strategi
implement
set
hendra
viru
infect
australia
vaccin
hors
aim
interrupt
transmiss
chain
hendra
viru
fruit
bat
hors
human
likewis
dromedari
camel
driver
zoonot
transmiss
merscov
vaccin
dromedari
camel
reduc
shed
merscov
would
like
limit
potenti
zoonot
transmiss
larg
fraction
dromedari
camel
middl
east
north
east
africa
antibodi
specif
merscov
degre
protect
reinfect
provid
antibodi
current
unclear
evid
point
abil
merscov
reinfect
dromedari
camel
despit
presenc
antibodi
serum
merscov
seroposit
camel
still
shed
detect
merscov
respiratori
tract
found
middl
east
howev
correl
strong
humor
respons
seroposit
adult
dromedari
camel
low
preval
merscov
observ
jordan
wherea
seroposit
young
camel
year
old
weaker
humor
respons
display
high
merscov
preval
suggest
antibodi
merscov
afford
protect
reinfect
viru
shed
observ
also
suggest
younger
anim
main
drive
forc
behind
circul
merscov
primari
target
vaccin
strategi
studi
highlight
sever
import
issu
consid
develop
dromedari
camel
vaccin
merscov
first
viru
shed
reduc
complet
absent
presenc
antibodi
dromedari
camel
vaccin
howev
viru
replic
vaccin
anim
larg
confin
nasal
turbin
wherea
merscov
replic
unvaccin
anim
extend
deeper
respiratori
tract
trachea
studi
use
intranas
administr
modifi
vaccinia
viru
ankara
viru
vector
vaccin
express
full
length
spike
protein
delay
shed
also
observ
one
vaccin
dromedari
camel
vaccin
low
neutral
antibodi
titer
detect
upper
respiratori
tract
appar
low
neutral
capac
upper
respiratori
tract
combin
continu
exposur
merscov
cohous
anim
could
potenti
deplet
neutral
capac
scaveng
avail
neutral
antibodi
neutral
capac
suffici
reduc
allow
viru
replic
therefor
vaccin
platform
aim
specif
induc
high
level
mucos
immun
induc
humor
well
cellular
immun
may
requir
complet
protect
indepth
studi
determin
correl
protect
dromedari
camel
would
aid
develop
bettertarget
vaccin
especi
correl
level
neutral
antibodi
serum
vs
protect
merscov
upper
respiratori
tract
second
respons
vaccin
dromedari
camel
vari
wide
one
three
camel
present
studi
respond
vaccin
camel
tenyearold
male
hous
pen
adjac
matur
femal
vaccin
schedul
coincid
mate
period
camel
thu
possibl
though
unclear
reproduct
statu
impact
camel
immun
respons
variabl
neutral
respons
merscov
vaccin
report
previou
dromedari
camel
vaccin
studi
one
anim
group
three
fail
mount
detect
neutral
respons
vaccin
dna
vaccin
express
full
length
spike
protein
vaccin
develop
effort
thu
focu
vaccin
platform
uniformli
induc
immun
dromedari
camel
final
intranas
challeng
merscov
yield
distinctli
differ
outcom
alpaca
dromedari
camel
upon
viral
challeng
immun
alpaca
complet
protect
merscov
infect
thu
although
alpaca
attract
altern
experiment
model
dromedari
camel
sinc
merscov
replic
dynam
alpaca
appear
similar
dromedari
camel
alpaca
easier
obtain
hous
vaccin
efficaci
ultim
confirm
dromedari
camel
model
